Join to View Full Profile
4220 Harding PikeSE Building Suite 200Nashville, TN 37205
Phone+1 615-385-3751
Fax+1 615-269-7085
Dr. Shih is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2000 - 2003
Vanderbilt University Medical CenterResidency, Internal Medicine, 1997 - 2000
Vanderbilt University School of MedicineClass of 1997
Certifications & Licensure
TN State Medical License 1998 - 2026
LA State Medical License 2003 - 2007
MD State Medical License 2000 - 2003
Clinical Trials
- Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Start of enrollment: 2011 Oct 01
- MEK162 for Patients With RAS/RAF/MEK Activated Tumors Start of enrollment: 2013 Oct 10
- Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
- Join now to see all
Publications & Presentations
PubMed
- A pilot survey into the landscape of neuro-oncology care in the community.Christine Lu-Emerson, Sajeel Chowdhary, Rupesh Kotecha, Akanksha Sharma, Yazmin Odia
The Oncologist. 2025-03-10 - A phase Ib study evaluating the c-MET inhibitor INC280 (capmatinib) in combination with bevacizumab in patients with high-grade glioma.Gerald S Falchook, James D Battiste, Amandeep Kalra, Mythili Shastry, Lindsey Finney
Neuro-Oncology Advances. 2024-12-11 - 28 citationsAvelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-upSandra P. D'Angelo, Shailender Bhatia, A.S. Brohl, Omid Hamid, Janice M. Mehnert
ESMO Open. 2021-10-26
Journal Articles
- Randomized Phase II Study of Akt Blockade with or Without Ipatasertib in Abiraterone-Treated Patients with Metastatic Prostate Cancer with and Without PTEN LossKent Shih, MD, Clinical Cancer Research
- A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced MalignanciesKent C Shih, Kyriakos P Papadopoulos, Drew W Rasco, Clinical Cancer Research
Press Mentions
- Brain Tumor Survivor Celebrates Birthday Virtually with Doctors Who Saved His LifeMarch 22nd, 2021
BeiGene Announces Preliminary Clinical Data on PARP Inhibitor Pamiparib Presented at Annual Scientific Meeting and Education Day of the Society for Neuro-OncologyNovember 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
